UZ Leuven
Leuven, 3000, Belgium
NCT Number: NCT02258035
The purpose of this study is to isolate genotype-specific DBP/Gc from homozygous human volunteers and use these purified proteins to cross-validate existing or novel assays for this serum protein and to evaluate the binding characteristics of these variants of DBP/Gc for different vitamin D metabolites.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Leuven, 3000, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Sampling of 100-150 ml of blood
Time frame: single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer
In vitro characterization
Time frame: single blood draw at time of consultation, an expected average 4 years after curative treatment for breast cancer
In vitro characterization
Universitaire Ziekenhuizen KU Leuven
Other
Isolation of Genotype-specific Isoforms of Human Vitamin D-binding Protein (DBP/Gc)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05694689
Avitaminosis, Deficiency Diseases
Galveston, Texas, United States
View Trial DetailsNCT05459298
Avitaminosis, Deficiency Diseases
Houston, Texas, United States
View Trial DetailsNCT07579637
Avitaminosis, Deficiency Diseases
New Cairo, Select A State Or Province, Egypt
View Trial DetailsNCT03613116
Avitaminosis, Cognition Disorders
Walnut Creek, California, United States
View Trial Details